General Information
Revision date
2015-06-09
Product name
DANAZOL
CAS No.
17230-88-5
Icons in SDS
Company Information
company name
Sanofi
e-mail address of the competent person responsible for the Safety Data Sheet
ProductStewardshipFrance@sanofi.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360D
Hazard statements
Code
Statements
H360D
May damage the unborn child
Section 2
CLP CLASSIFICATION
Reproductive toxicity, Category 1B H360D: May damage the unborn child.
2.2 Label elements
CLP/GHS-Labelling (REGULATION (EC) No 1272/2008)
Signal word
Danger
Hazard statements
H360D: May damage the unborn child.
Precautionary statements
P201: Obtain special instructions before use. P243: Take precautionary measures against static discharge. P260: Do not breathe dust. P263: Avoid contact during pregnancy/ while nursing. P281: Use personal protective equipment as required. P308 + P313 IF exposed or concerned Get medical advice/ attention P403 + P233: Store in a well-ventilated place. Keep container tightly closed. P501: Dispose of contents/ container to an approved waste disposal plant.
2.3 Other hazards
Physical, chemical and High risk of dust explosion. toxicological hazards May be harmful by prolonged exposure by inhalation, in contact with skin or if swallowed. Substance pharmacologically active.
Environmental effects
No data available on environmental effects. Sanofi hazard bands: Hygiene : OEB 3 G2 (approved) Safety : SHB 5 Further information see chapter 16.
